114 related articles for article (PubMed ID: 34189832)
1. Metabolic improvement with short-term, glucagon-like peptide-1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
Bojer AS; Sørensen MH; Bjerre J; Gaede P; Vejlstrup N; Madsen PL
Diabetes Obes Metab; 2021 Oct; 23(10):2374-2384. PubMed ID: 34189832
[TBL] [Abstract][Full Text] [Related]
2. Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study.
Kumarathurai P; Sajadieh A; Anholm C; Kristiansen OP; Haugaard SB; Nielsen OW
Cardiovasc Diabetol; 2021 Jan; 20(1):12. PubMed ID: 33413428
[TBL] [Abstract][Full Text] [Related]
3. Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial.
Bizino MB; Jazet IM; Westenberg JJM; van Eyk HJ; Paiman EHM; Smit JWA; Lamb HJ
Cardiovasc Diabetol; 2019 Apr; 18(1):55. PubMed ID: 31039778
[TBL] [Abstract][Full Text] [Related]
4. Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial.
Jørgensen PG; Jensen MT; Mensberg P; Storgaard H; Nyby S; Jensen JS; Knop FK; Vilsbøll T
Diabetes Obes Metab; 2017 Jul; 19(7):1040-1044. PubMed ID: 28188972
[TBL] [Abstract][Full Text] [Related]
5. Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double-Blind, Randomized, Placebo-Controlled Trial.
Paiman EHM; van Eyk HJ; van Aalst MMA; Bizino MB; van der Geest RJ; Westenberg JJM; Geelhoed-Duijvestijn PH; Kharagjitsingh AV; Rensen PCN; Smit JWA; Jazet IM; Lamb HJ
J Magn Reson Imaging; 2020 Jun; 51(6):1679-1688. PubMed ID: 31799782
[TBL] [Abstract][Full Text] [Related]
6. Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation.
Bizino MB; Jazet IM; de Heer P; van Eyk HJ; Dekkers IA; Rensen PCN; Paiman EHM; Lamb HJ; Smit JW
Diabetologia; 2020 Jan; 63(1):65-74. PubMed ID: 31690988
[TBL] [Abstract][Full Text] [Related]
7. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Margulies KB; Hernandez AF; Redfield MM; Givertz MM; Oliveira GH; Cole R; Mann DL; Whellan DJ; Kiernan MS; Felker GM; McNulty SE; Anstrom KJ; Shah MR; Braunwald E; Cappola TP;
JAMA; 2016 Aug; 316(5):500-8. PubMed ID: 27483064
[TBL] [Abstract][Full Text] [Related]
8. A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes.
Webb DR; Htike ZZ; Swarbrick DJ; Brady EM; Gray LJ; Biglands J; Gulsin GS; Henson J; Khunti K; McCann GP; Waller HL; Webb MA; Sargeant JA; Yates T; Zaccardi F; Davies MJ
Diabetes Obes Metab; 2020 Jul; 22(7):1187-1196. PubMed ID: 32157772
[TBL] [Abstract][Full Text] [Related]
9. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study.
Kumarathurai P; Anholm C; Nielsen OW; Kristiansen OP; Mølvig J; Madsbad S; Haugaard SB; Sajadieh A
Cardiovasc Diabetol; 2016 Jul; 15(1):105. PubMed ID: 27455835
[TBL] [Abstract][Full Text] [Related]
10. Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study.
Myat A; Arri S; Bhatt DL; Gersh BJ; Redwood SR; Marber MS
Cardiovasc Diabetol; 2015 Feb; 14():27. PubMed ID: 25848859
[TBL] [Abstract][Full Text] [Related]
11. Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes.
Lambadiari V; Pavlidis G; Kousathana F; Varoudi M; Vlastos D; Maratou E; Georgiou D; Andreadou I; Parissis J; Triantafyllidi H; Lekakis J; Iliodromitis E; Dimitriadis G; Ikonomidis I
Cardiovasc Diabetol; 2018 Jan; 17(1):8. PubMed ID: 29310645
[TBL] [Abstract][Full Text] [Related]
12. Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
Jorsal A; Kistorp C; Holmager P; Tougaard RS; Nielsen R; Hänselmann A; Nilsson B; Møller JE; Hjort J; Rasmussen J; Boesgaard TW; Schou M; Videbaek L; Gustafsson I; Flyvbjerg A; Wiggers H; Tarnow L
Eur J Heart Fail; 2017 Jan; 19(1):69-77. PubMed ID: 27790809
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review of Glucagon-Like Peptide One Receptor Agonist Liraglutide of Subjects with Heart Failure with Reduced Left Ventricular Ejection Fraction.
Hamad F; Elnour AA; Elamin A; Mohamed S; Yousif I; Don J; Abdi S; Al Amoodi A; Fathelrahman AI; Gnana K; Alanzi F; Abubakar AB; Magboul SM; Ahmed SA; Sadeq A
Curr Diabetes Rev; 2021; 17(3):280-292. PubMed ID: 32867644
[TBL] [Abstract][Full Text] [Related]
14. Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial.
Smits MM; Tonneijck L; Muskiet MH; Hoekstra T; Kramer MH; Diamant M; van Raalte DH
Eur J Endocrinol; 2017 Jan; 176(1):77-86. PubMed ID: 27777261
[TBL] [Abstract][Full Text] [Related]
15. Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction.
Yagi K; Imamura T; Tada H; Chujo D; Liu J; Shima Y; Ohbatake A; Miyamoto Y; Okazaki S; Ito N; Nakano K; Shikata M; Enkaku A; Takikawa A; Honoki H; Fujisaka S; Origasa H; Tobe K
J Diabetes Res; 2021; 2021():8838026. PubMed ID: 33855087
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral antidiabetic drugs and glucagon-like peptide-1 receptor agonists on left ventricular diastolic function in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis.
Ida S; Kaneko R; Imataka K; Okubo K; Shirakura Y; Azuma K; Fujiwara R; Takahashi H; Murata K
Heart Fail Rev; 2021 Sep; 26(5):1151-1158. PubMed ID: 32080782
[TBL] [Abstract][Full Text] [Related]
17. Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
Liakos A; Lambadiari V; Bargiota A; Kitsios K; Avramidis I; Kotsa K; Gerou S; Boura P; Tentolouris N; Dimitriadis G; Tsapas A
Diabetes Obes Metab; 2019 Mar; 21(3):517-524. PubMed ID: 30242948
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial.
Miras AD; Pérez-Pevida B; Aldhwayan M; Kamocka A; McGlone ER; Al-Najim W; Chahal H; Batterham RL; McGowan B; Khan O; Greener V; Ahmed AR; Petrie A; Scholtz S; Bloom SR; Tan TM
Lancet Diabetes Endocrinol; 2019 Jul; 7(7):549-559. PubMed ID: 31174993
[TBL] [Abstract][Full Text] [Related]
19. The effect of liraglutide on renal function: A randomized clinical trial.
von Scholten BJ; Persson F; Rosenlund S; Hovind P; Faber J; Hansen TW; Rossing P
Diabetes Obes Metab; 2017 Feb; 19(2):239-247. PubMed ID: 27753201
[TBL] [Abstract][Full Text] [Related]
20. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study.
Kumarathurai P; Anholm C; Fabricius-Bjerre A; Nielsen OW; Kristiansen O; Madsbad S; Haugaard SB; Sajadieh A
J Hypertens; 2017 May; 35(5):1070-1078. PubMed ID: 28129251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
